Skip to main content
Log in

Not less but different: psychotropic drug utilization trends in Norwegian nursing homes during a 12-year period. The Bergen District Nursing Home (BEDNURS) Study

  • Original Articles
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Background and aims: The use of psychotropic drugs in nursing homes is generally considered to be inappropriately high. The aim of the present survey was to compare psychotropic drug use in nursing homes (NHs) in 1985 relative to 1996/97, and to explore predictors for this drug use. Methods: Cross-sectional study. Mental capacity was assessed by means of the Clinical DementiaRating scale (CDR), and behavior registered by trained nurses. Scheduled, daily use of psychotropic drugs among long-term care residents in 1985 (N=1247) and 1996/97 (N=1035) was recorded. Bivariate analyses and logistic regression analyses were applied to establish predictors for psychoactive drug use. Results: From 1985 to 1996/97, the proportion of residents using any psychotropic drug increased from 52 to 57%. Antipsy-chotic drug use decreased from 33 to 22%, while anxiolytics increased from 11 to 16%, hypnotics from 11 to 14%, and antidepressants from 12 to 31%. Psychotropic drug use was predominantly associated with behavioral symptoms and not with mental impairment. Concurrent use of two or more psychotropic drugs increased from 23 to 32% of all psychotropic users. Conclusions: During the study period, a substantial decline in the use of antipsychotics was observed, but a generally increased overall use of psychotropic drugs, particularly antidepressants. Psychotropic drug treatment was mainly associated with behavioral symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Beardsley RS, Larson DB, Burns BJ, Thompson JW, Kamerow DB. Prescribing of psychotropics in elderly nursing home patients. J Am Geriatr Soc 1989; 37: 327–30.

    PubMed  CAS  Google Scholar 

  2. Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117: 684–9.

    Article  PubMed  CAS  Google Scholar 

  3. Nygaard HA, Bakke K, Breivik K, Brudvik E. Mental and physical capacity and consumption of neuroleptic drugs in residents of nursing homes. Int J Geriatr Psychiatry 1990; 5: 303–8.

    Article  Google Scholar 

  4. Sørensen L, Foldspang A, Gulmann N, Munk-Jørgensen P. Determinants for the use of psychotropics among nursing home residents. Int J Geriatr Psychiatry 2001; 16: 147–54.

    Article  PubMed  Google Scholar 

  5. Draper B, Brodaty H, Low L-F, et al. Use of psychotropics in Sydney nursing homes: association with depression, psychosis, and behavioral disturbances. Int Psychogeriatr 2001; 13: 107–20.

    Article  PubMed  CAS  Google Scholar 

  6. Wancata J, Benda N, Hajji M, Lesch O. Prevalence and course of psychiatric disorders among nursing home admissions. Soc Psychiatry Psychiatr Epidemiol 1998; 33: 74–9.

    Article  PubMed  CAS  Google Scholar 

  7. Wancata J, Benda N, Meise U, Müller C. Psychotropic drug intake in residents newly admitted to nursing homes. Psychopharmacology 1997; 134: 115–20.

    Article  PubMed  CAS  Google Scholar 

  8. Avorn J, Soumerai SB, Everitt DE, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 1992; 327: 168–73.

    Article  PubMed  CAS  Google Scholar 

  9. Furniss L, Burns A, Craig S, Scobie S, Cooke J, Faragher B. Effects of a pharmacist’s medication review in nursing homes. Br J Psychiatry 2000; 176: 563–7.

    Article  PubMed  CAS  Google Scholar 

  10. Stoudemire A, Smith D. OBRA regulations and the use of psychotropic drugs in long-term care facilities. Impact and implications for geropsychiatric care. Gen Hosp Psychiatry 1996; 18: 77–94.

    Article  CAS  Google Scholar 

  11. Semla TP, Palla K, Poddig B, Brauner DJ. Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents. J Am Geriatr Soc 1994; 42: 648–52.

    PubMed  CAS  Google Scholar 

  12. Borson S, Doane K. The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities. Psychiat Serv 1997; 48: 1289–96.

    CAS  Google Scholar 

  13. Llorente MD, Olsen EJ, Leyva O, Silverman MA, Lewis JE, Rivero J. Use of antipsychotic drugs in nursing homes: current compliance with OBRA regulations. J Am Geriatr Soc 1998; 46: 198–201.

    PubMed  CAS  Google Scholar 

  14. Medical Products Agency and The Norwegian Medical Control Authority. Treatment of mental conditions in patients with dementia. Workshop. 1994. Uppsala, 1995.

  15. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for staging of dementia. Br J Psychiatry 1982; 140: 566–72.

    Article  PubMed  CAS  Google Scholar 

  16. Adolfsson R, Gottfries CG, Nyström L, Winblad B. Prevalence of dementia disorders in institutionalized Swedish old people. The work load imposed by caring for these patients. Acta Psychiatr Scand 1981; 63: 225–44.

    Article  CAS  Google Scholar 

  17. World Health Organization. Anatomical Therapeutical Chemical (ATC) classification index including defined daily doses (DDD) for plain substances. Oslo: World Health Organization Collaborating Center for Drug Statistics Methodology, 1997.

    Google Scholar 

  18. Nygaard HA, Ruths S. Missing the diagnosis: senile dementia in patients admitted to nursing homes. Scand J Prim Health Care 2003; 21: 148–52.

    Article  PubMed  Google Scholar 

  19. Skoog I, Nilsson L, Landahl S, Steen B. Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. Int Psychogeriatr 1993; 5: 33–48.

    Article  PubMed  CAS  Google Scholar 

  20. Nygaard HA, Brudvik E, Juvik OB, Pedersen WE, Rotevatn TS, Vollset Å. Consumption of psychotropic drugs in nursing home residents: a prospective study in patients permanently admitted to a nursing home. Int J Geriatr Psychiatry 1994; 9: 387–91.

    Article  Google Scholar 

  21. Conn D, Ferguson I, Mandelman K, Ward C. Psychotropic drug utilization in long-term care facilities for the elderly in Ontario. Canada. Int Psychogeriatr 1999; 11: 223–33.

    Article  CAS  Google Scholar 

  22. Schmidt I, Claesson C, Westerholm B, Nilsson L, Svarstad B. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc 1998; 46: 77–82.

    PubMed  CAS  Google Scholar 

  23. Giron M, Forsell Y, Bernsten C, Thorslund M, Winblad B, Fastbom J. Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry 2001; 16: 900–6.

    Article  PubMed  CAS  Google Scholar 

  24. Schmidt I. Fastbom J. Quality of drug use in Swedish nursing homes. A follow-up study. Clin Drug Invest 2000; 20: 433–46.

    Article  Google Scholar 

  25. Arthur A, Matthews R, Jagger C, Lindesay J. Factors associated with antidepressant treatment in residential care: changes between 1990 and 1997. Int J Geriatr Psychiatry 2002; 17: 54–60.

    Article  PubMed  Google Scholar 

  26. McGrath A, Jackson G. Survey of neuroleptic prescribing in residents of nursing homes in Glasgow. BMJ 1996; 312: 611–2.

    Article  PubMed  CAS  Google Scholar 

  27. van Dijk KN, de Vries CS, van den Berg PB, Brouwers JRBJ, de Jong-van den Berg LTW. Drug utilisation in Dutch nursing homes. Eur J Clin Pharmacol 2000; 55: 765–71.

    Article  PubMed  Google Scholar 

  28. Castle N. Changes in resident and facility risk factors for psychotropic drug use in nursing homes since the Nursing Home Reform Act. J Applied Gerontol 1999; 18: 77–98.

    Article  Google Scholar 

  29. Lindesay J, Matthews R, Jagger C. Factors associated with antipsychotic drug use in residential care: changes between 1990 and 1997. Int J Geriatr Psychiatry 2003; 18: 511–9.

    Article  PubMed  Google Scholar 

  30. Macdonald A, Carpenter G, Box O, Roberts A. Dementia and use of psychotropic medication in non-“Elderly Mentally Infirm” nursing homes in South East England. Age Ageing 2002; 31: 58–64.

    Article  PubMed  Google Scholar 

  31. Lasser RA, Sunderland T. Newer psychotropic medication use in nursing home residents. J Am Geriatr Soc 1998; 46: 202–7.

    PubMed  CAS  Google Scholar 

  32. Ruths S, Straand J, Nygaard HA. Psychotropic drug use in nursing homes — diagnostic indications and variations between institutions. Eur J Clin Pharmacol 2001; 57: 523–8.

    Article  PubMed  CAS  Google Scholar 

  33. Lyketsos CG, Steele C, Galik E, et al. Physical aggression in dementia patients and its relationship to depression. Am J Psychiatry 1999; 156: 66–71.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Harald A. Nygaard MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nygaard, H.A., Ruths, S., Straand, J. et al. Not less but different: psychotropic drug utilization trends in Norwegian nursing homes during a 12-year period. The Bergen District Nursing Home (BEDNURS) Study. Aging Clin Exp Res 16, 277–282 (2004). https://doi.org/10.1007/BF03324552

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03324552

Keywords

Navigation